BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23542458)

  • 1. RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.
    Guerrero-Setas D; Pérez-Janices N; Blanco-Fernandez L; Ojer A; Cambra K; Berdasco M; Esteller M; Maria-Ruiz S; Torrea N; Guarch R
    Mod Pathol; 2013 Aug; 26(8):1111-22. PubMed ID: 23542458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas.
    Perez-Janices N; Blanco-Luquin I; Tuñón MT; Barba-Ramos E; Ibáñez B; Zazpe-Cenoz I; Martinez-Aguillo M; Hernandez B; Martínez-Lopez E; Fernández AF; Mercado MR; Cabada T; Escors D; Megias D; Guerrero-Setas D
    Oncotarget; 2015 Jan; 6(1):368-80. PubMed ID: 25621889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix.
    Blanco-Luquin I; Guarch R; Ojer A; Pérez-Janices N; Martín-Sánchez E; Maria-Ruiz S; Monreal-Santesteban I; Blanco-Fernandez L; Pernaut-Leza E; Escors D; Guerrero-Setas D
    Pathol Int; 2015 Sep; 65(9):476-85. PubMed ID: 26222671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
    Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
    J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.
    Perez-Janices N; Blanco-Luquin I; Torrea N; Liechtenstein T; Escors D; Cordoba A; Vicente-Garcia F; Jauregui I; De La Cruz S; Illarramendi JJ; Coca V; Berdasco M; Kochan G; Ibañez B; Lera JM; Guerrero-Setas D
    Oncotarget; 2015 Sep; 6(27):23944-58. PubMed ID: 26284587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.
    Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Ishizuka T; Saito R; Nakajima T; Mori M
    Int J Oncol; 2007 Jul; 31(1):169-73. PubMed ID: 17549418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
    Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
    Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
    Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer.
    Endoh M; Tamura G; Honda T; Homma N; Terashima M; Nishizuka S; Motoyama T
    Br J Cancer; 2005 Dec; 93(12):1395-9. PubMed ID: 16265349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women].
    Niyazi M; Liu XW; Zhu KC
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):31-4. PubMed ID: 22490852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Shen S; Guo X; Kuang G; Yang Z
    Mol Carcinog; 2016 Nov; 55(11):1655-1666. PubMed ID: 26456015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
    Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
    PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
    Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
    Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance.
    Mitra S; Mazumder Indra D; Basu PS; Mondal RK; Roy A; Roychoudhury S; Panda CK
    Mol Carcinog; 2012 Sep; 51(9):723-33. PubMed ID: 21809394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma.
    Guerrero D; Guarch R; Ojer A; Casas JM; Ropero S; Mancha A; Pesce C; Lloveras B; Garcia-Bragado F; Puras A
    BJU Int; 2008 Sep; 102(6):747-55. PubMed ID: 18336597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation of SFRPs gene family in cervical cancer.
    Chung MT; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Chu TY; Lai HC; Lin YW
    Gynecol Oncol; 2009 Feb; 112(2):301-6. PubMed ID: 19038436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer.
    Kitkumthorn N; Yanatatsanajit P; Kiatpongsan S; Phokaew C; Triratanachat S; Trivijitsilp P; Termrungruanglert W; Tresukosol D; Niruthisard S; Mutirangura A
    BMC Cancer; 2006 Mar; 6():55. PubMed ID: 16524460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.